Kristen Ambrose Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Feb 03, 2022
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
3.96K sh
1,394 → 3,960
Equity Change
+184.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Kristen Ambrose CIK 0001856587 |
CAO
|
Kristen Ambrose at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,978,865
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-09-01 | Award | — | View |
| 2026-03-02 | Sell | -$172,560 | View |
| 2026-02-26 | Sell | -$108,456 | View |
| 2026-02-19 | Sell | -$1,064,297 | View |
| 2026-02-18 | - | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2022-02-01 | A - Award/Grant | 2,566 A | $0.00 | — | 3,960 | Direct |
Footnotes (1)
- F1
- Restricted stock unit award that vests in installments beginning on 02/24/2023. Show more
Remarks
Exhibit 24 - Power of Attorney
Show moreRelated filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0001209191-22-006761
API docs
View Original SEC Filing